A Mengarelli - Department of Oncology, Regima Elena National Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 115 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The PI3Kδ Inhibitor Zandelisib on Intermittent Dosing in Relapsed/refractory Follicular Lymphoma: Results from a Global Phase 2 Study

Andrew D. Zelenetz,Wojciech Jurczak,Vincent Ribrag,Kim Linton,Graham P. Collins, Javier L. Jimenez,Mark Bishton,Bhagirathbhai Dholaria,Andrea Mengarelli,Tycel J. Phillips, Nagendraprasad Sungala,Gerardo Musuraca,Oonagh Sheehy, Eric Van Den Neste,Mitsuhiko Odera, Lu Miao,Daniel P. Gold,Richard G. Ghalie,Pier L. Zinzani

HEMASPHEREno. 8 (2024)

Cited0Views0WOSBibtex

Pb2416: efficacy and safety of biosimilar pegfilgrastim after autologous stem cell transplant: a comparative study with biosimilar filgrastim, lenograstim and originator pegfilgrastim

Francesco Marchesi,Elena Papa,Paolo Falcucci,Svitlana Gumenyuk,Francesca Palombi,Francesco Pisani,Daniela Renzi,Atelda Romano,Antonio Spadea,Giulia Regazzo,Maria Giulia Rizzo,Iole Cordone,Maria Laura Foddai,Andrea Mengarelli

HemaSphereno. S3 (2023): e1507485-e1507485

Cited0Views0Bibtex

Refinement of MRD Assessment in Hairy Cell Leukemia by Integrated Molecular and Flow Cytometry Analysis

G. Urbani,M. Allegretti, V. De Pascale,S. Masi,A. Pasquale,F. Marchesi,A. Mengarelli, F. Pisani,G. Blandino,D. Renzi,I. Cordone

The Journal of Liquid Biopsy (2023): 100060-100060

Cited0Views0Bibtex

IBCL-271 Primary Efficacy and Safety Analysis of a Global Phase II Study of Zandelisib Administered by Intermittent Dosing (ID) in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): the TIDAL Study

Tycel Phillips,Wojciech Jurczak,Vincent Ribrag,Kim Linton, Graham P. Collin,Javier Lopez-Jimenez,Nishitha Reddy,Andrea Mengarelli,Gerardo Musuraca,Oonagh Sheehy,Weiming Xu,Michel Azoulay,Richard G. Ghalie,Pier Luigi Zinzani,Andrew D. Zelenetz

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2022): S172-S172

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn